About Michael Bell

This author has not yet filled in any details.
So far Michael Bell has created 18 blog entries.
3 Jan, 2019

CIRCULOGENE Expands Molecular Diagnostics Testing Footprint To Asia-Pacific Region

DATE: January 3, 2019 CIRCULOGENE Expands Molecular Diagnostics Testing Footprint To Asia-Pacific Region Strategic partnership broadens cancer-targeted molecular diagnostics and immunotherapy testing to rapidly growing Asia-Pacific market. BIRMINGHAM, Ala.– CIRCULOGENE, advancing precision medicine through molecular genetics [...]

20 Dec, 2018

CIRCULOGENE to Launch Comprehensive, 20-Fusion NTRK Biomarker Testing in Early 2019

FOR IMMEDIATE RELEASE DATE: December 20, 2018 CIRCULOGENE to Launch Comprehensive, 20-Fusion NTRK Biomarker Testing in Early 2019 Proprietary, cfRNA-enriched, real-time PCR testing rapidly identifies all patients with NTRK fusion-positive cancers potentially eligible for new TRK [...]

19 Sep, 2018

CIRCULOGENE Expands Testing Menu with Somatic BRCA1/2 Blood Testing

CIRCULOGENE Expands Testing Menu with Somatic BRCA1/2 Blood Testing Enables paired somatic-germline testing, broadens targeted treatment population for breast, ovarian, pancreatic and prostate cancers   BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through molecular genetics testing, has [...]

19 Jun, 2018

CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients Independent UAB study demonstrates potential value of company’s molecular testing in noninvasive, serial tracking of genomic changes in treatment-resistant ovarian cancer BIRMINGHAM, Ala.– [...]

29 May, 2018

REQUEST FOR APPLICATIONS CIRCULOGENE – RESEARCH SAMPLE PROFILING PILOT AWARD PROGRAM

REQUEST FOR APPLICATIONS CIRCULOGENE – RESEARCH SAMPLE PROFILING PILOT AWARD PROGRAM Applications due: 5pm EST on August 1, 2018 Award announcements: anticipated by September 15, 2018 Pilot Award Details: Made possible by CIRCULOGENE, this pilot [...]

23 May, 2018

CLINICAL SUCCESS STORY No. 4285

Advanced molecular genetics testing delivers lung cancer treatment decision with 5-day international turnaround. An Israeli oncologist referred his 63-year-old female lung cancer patient to the personalized cancer testing expertise of CIRCULOGENE looking for a faster treatment [...]

23 May, 2018

CLINICAL SUCCESS STORY No. 4518

Single-tube liquid biopsy overcomes tissue biopsy failure to give oncologist personalized treatment decision guidance in matter of days. A southeastern oncologist treating a 66-year-old male with lung cancer was unable to obtain testing results due [...]

23 May, 2018

CLINICAL SUCCESS STORY No. 4521

CIRCULOGENE testing rapidly matches young patient with targeted therapy for rare non-small-cell lung cancer genetic variation. An oncologist referred a blood sample on his 44-year-old female non-small cell lung cancer (NSCLC) patient to CIRCULOGENE for [...]

12 Jan, 2018

Pre-Analytical Assessment of Circulating Cell-Free DNA Prepared by An Isolation-Free Enrichment Technology

Publication: ACTA Scientific Cancer Biology Volume 2 Issue 1 January 2018 Abstract Quantity and quality of circulating cell-free DNA (cfDNA) from plasma is highly variable, with frequent contamination of larger, genomic DNA as a consequence [...]

3 Jan, 2018

CIRCULOGENE Announces International Licensing of Proprietary Molecular Diagnostics Testing Technology to Turkey-Based Laboratory

CIRCULOGENE Announces International Licensing of Proprietary Molecular Diagnostics Testing Technology to Turkey-Based Laboratory Company expands single-blood-tube, cancer-targeted therapy and immunotherapy testing to parts of Europe, Africa, the Middle East and Commonwealth of Independent States (CIS) [...]